GlassScriptPhysician profile
Debra A Equihua
NPI 1396819355
$846.34
in general payments reported to CMS, 2019-2025
13 companies · $181 in 2025
The $181 reported for 2025 was more than what 78% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.84 · 2022: $33.52 · 2023: $288 · 2024: $315 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $234.57 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $179.71 | 2021-2024 | Myosure Tissue Removal Device, Acessa Provu System |
| Organon LLC | $118.70 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $59.61 | 2023-2024 | Slynd |
| Mayne Pharma Commercial LLC | $48.70 | 2023-2025 | |
| Pfizer INC. | $47.70 | 2024 | |
| Shield Therapeutics INC | $32.63 | 2023-2024 | Accrufer |
| Dexcom, INC. | $29.82 | 2024-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $27.27 | 2025 | Cologuard Collection Kit |
| Ethicon US, LLC | $19.72 | 2025 | Dermabond Prineo, Vistaseal, Ethicon |
| Abbott Laboratories | $17.62 | 2023 | Freestyle Libre |
| Coopersurgical, INC. | $15.22 | 2025 | Paragard T 380a |
| Boston Scientific Corporation | $15.07 | 2025 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Equihua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.